US Patent Issued to SUNSHINE LAKE PHARMA on May 27 for "RET inhibitors, pharmaceutical compositions and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,348, issued on May 27, was assigned to SUNSHINE LAKE PHARMA Co. LTD. (Dongguan, China).

"RET inhibitors, pharmaceutical compositions and uses thereof" was invented by Hongming Xie (Dongguan, China), Ming Luo (Dongguan, China), Jianli Wu (Dongguan, China), Yingjun Zhang (Dongguan, China) and Yingchao Cheng (Dongguan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A RET inhibitor, a pharmaceutical composition thereof and uses thereof. In particular, the present invention provides a compound having Formula (I) or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug th...